Clinical Trials on PRETEXT I Hepatoblastoma

Total 2977 results

National Cancer Institute (NCI)

Active, not recruiting

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

PRETEXT I Hepatoblastoma | PRETEXT II Hepatoblastoma | PRETEXT III Hepatoblastoma | PRETEXT IV Hepatoblastoma

United States, Canada, Puerto Rico, Australia, Japan, Brazil
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer

Recurrent Childhood Liver Cancer | Childhood Hepatoblastoma | Stage I Childhood Liver Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tissue Samples From Young Patients With Liver Cancer

Childhood Hepatoblastoma | Stage I Childhood Liver Cancer | Stage II Childhood Liver Cancer | Stage III Childhood Liver Cancer | Stage IV Childhood Liver Cancer

United States
Children's Hospital Medical Center, Cincinnati

Recruiting

Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative

Refractory Hepatoblastoma | Relapsed Hepatoblastoma

United States
Assiut University

Recruiting

Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience

Hepatoblastoma

Egypt
Emory University

Withdrawn

Hepatoblastoma Biology Study and Tissue Bank

Hepatoblastoma

United States
RenJi Hospital

Completed

Evaluation of Lung Metastases Based on Ultrashort Echo Time MRI

Hepatoblastoma | Radiology

China
TRPHARM
Fennec Pharma

Available

A Compassionate Use Program to Provide Access to Sodium Thiosulfate

Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma

Turkey
University of Illinois at Chicago

Terminated

Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies

Focus: Prevent Preterm Delivery | Incidental Short Cervix at Mid-trimester

United States
Federal Research Institute of Pediatric Hematology...

Unknown

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Anesthesia | Pediatric Cancer | Beta-Thalassemia | Hepatic Metastases | Pediatric Tumor | Pediatric Hepatoblastoma

Russian Federation
Shanghai Children's Medical Center
Shanghai Children's Hospital

Recruiting

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Hepatoblastoma

China
University of Leicester

Unknown

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

Liver Cancer

France, United Kingdom, Netherlands, Ireland
Cairo University

Completed

Blind Versus Fiberoptic Intubation Through I-GEL

I-gel

Egypt
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder (ATLAS)

Bipolar I

United States, France, Romania, Poland, Canada, Hungary, Japan, Korea, Republic of, Malaysia, Taiwan
Cairo University

Unknown

3D Evaluation of Nasolabial Changes Following Classic Versus Modified Alar Base Suture After Le Fort I Osteotomy

Le Fort; I
Solvay Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/S

Completed

PK Effects of Bifeprunox & Valproate in Bipolar I

Bipolar I Disorder

United States
University of Sao Paulo

Completed

Efficacy of Combined Treatment for Young Bipolar I Disorder (LICAVAL)

Bipolar I Disorder

Brazil
University of Sao Paulo

Unknown

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients (ARIQUELI)

Bipolar I Disorder

Brazil
Hams Hamed Abdelrahman

Completed

Computer-Aided Design/Manufacturing for Le Fort I Osteotomy and 3D-customized Titanium Plate in Orthognathic Surgery

Le Fort; I

Egypt
Cairo University

Unknown

Waferless One Stage Segmental Lefort I Maxillary Positioning in Transverse Deficiency

Lefort I Osteotomy
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Bipolar I Disorder

United States, Taiwan, Romania, Korea, Republic of, Japan, Poland, Canada
Professor Saad Shakir
Merck Sharp & Dohme LLC

Completed

An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)

Bipolar I Disorder

United Kingdom
Merck Sharp & Dohme LLC

Recruiting

A Study of MK-8189 in Participants With Bipolar I Disorder (MK-8189-020)

Bipolar I Disorder

United States
Future University in Egypt

Completed

Accuracy of LeFort I Osteotomy Fixation Using Two Plates Versus Four Plates Patient Specific Osteosynthesis

Le Fort; I

Egypt
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions

Bipolar I Disorder

United States
Eli Lilly and Company

Completed

A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients

Bipolar I Disorder

United States
Cairo University

Not yet recruiting

Evaluation of Resin Composite Posterior Restorations Using Modeling Resin Insertion Technique in Class I Lesions

Class I Composite Restorations
Bayer

Completed

Study in Postmenopausal Women to Investigate the Drug-drug Interaction (DDI) Between Itraconazole(ITZ) and Orally Administered Vilaprisan; Absolute Bioavailability Using Intravenous Microtracer Dose of [14C]Vilaprisan

Clinical Trial, Phase I

United Kingdom
University Hospital, Basel, Switzerland

Completed

Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or Inhibition

Metabolic Detoxication, Phase I

Switzerland
Creative Testing Solutions

Completed

Evaluation of InnoLIA HTLV I/II Score

Human T-Lymphotrophic Virus Type I and/or Type II

United States
Mansoura University

Active, not recruiting

Compartive Evalution of the Efficiency of Maxillary Canine Retraction Using Power Chain Versus Burstone T-loop

Class I Malocclusion

Egypt
Bayer

Completed

Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)

Clinical Trial ,Phase I

Germany
Bayer

Completed

Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan

Clinical Trial, Phase I

Germany
Societe Internationale d'Oncologie Pediatrique

Completed

Chemotherapy in Treating Children With Liver Cancer

Liver Cancer

Italy
Children's Cancer and Leukaemia Group

Unknown

Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma

Liver Cancer

United Kingdom, Netherlands, Ireland
RenJi Hospital

Not yet recruiting

Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy (sPLENTY-pc)

Pediatric Cancer | Liver Cancer | Hepatoblastoma | Pediatric Solid Tumor | Transitional Cell Tumor

China
Postgraduate Institute of Dental Sciences Rohtak

Completed

Effect of Systemic Administration of Vitamin D on the Rate of Orthodontic Tooth Movement - A Randomized Control Trial

Angle Class I

India
University of Nebraska
Bristol-Myers Squibb

No longer available

Prospective Analysis and Comparison of Stress Echo to Real-Time Myocardial Contrast Stress Echo

Evaluation of Troponin I Levels

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions

Treatment for Bipolar I Disorder

United States
Bayer

Completed

Rogaratinib (BAY1163877) Human Mass Balance Study

Pharmacokinetics | Clinical Trial, Phase I

Netherlands
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Optimizing Response to Li Treatment Through Personalized Evaluation of Individuals With Bipolar I Disorder: The R-LiNK Initiative (R-LiNK)

Bipolar I Disorder

France
Forest Laboratories

Completed

Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)

Bipolar I Disorder

United States
Alkermes, Inc.

Completed

Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder

Bipolar I Disorder

United States
Bayer

Completed

First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784

Clinical Trials, Phase I as Topic

Germany
Shanghai Children's Medical Center
The First Affiliated Hospital of Anhui Medical University; Zhengzhou Children... and other collaborators

Completed

PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants (PIVKA-II)

Hepatoblastoma | Hepatic Hemangioendothelioma

China
Jina Pharmaceuticals Inc.
Novum Pharmaceutical Research Services; Lambda Therapeutic Research Ltd.; Intas...

Recruiting

Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

Bipolar I Disorder

United States
ZandA Technologies, llc
KGK Science Inc.

Completed

The Efficacy and Safety of an Amino Acid Supplement in Adults

Healthy | Insulin-Like Growth Factor I

Canada
Kafrelsheikh University

Completed

Ridge Splitting With Simultaneous Implant Placement Using i-PRF

Dental Implant | Ridge Splitting | i-PRF

Egypt
Sumitomo Pharma Co., Ltd.

Completed

A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.

Bipolar I Disorder

Japan, Lithuania, Malaysia, Philippines, Russian Federation, Slovakia, Taiwan, Ukraine
Bayer

Completed

BAY 1902607: Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Bioavailability, Food Effect

Clinical Trials, Phase I as Topic

Germany

Clinical Trials on PRETEXT I Hepatoblastoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations